Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

UK MHRA grants marketing authorization to Telix’s prostate cancer PET imaging agent, Illuccix: Melbourne, Australia Friday, February 14, 2025, 10:00 Hrs [IST] Telix, a commercia ...

A new scanner which uses nuclear technology ... showing how well an organ, bone or internal system is working and any abnormalities. For some patients, the scan time will be more than halved ...

Radiation from patients undergoing other diagnostic and therapeutic radionuclide procedures such as bone scans or radioiodine therapy may ... set by each country for each staff category (nuclear ...

PSMA PET scans enable precise detection of prostate cancer even in its earliest stages, improving diagnostic accuracy and enabling timely interventions.